The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis
Open accessAbstract
Diabetic nephropathy is the leading cause of end-stage renal disease. Patients with diabetic nephropathy have a high cardiovascular risk, comparable to patients with coronary heart disease. Accordingly, identification and management of risk factors for diabetic nephropathy as well as timely diagnosis and prompt management of the condition are of paramount importance for effective treatment. A variety of risk factors promotes the development and progression of diabetic nephropathy, including elevated glucose levels, long duration of diabetes, high blood pressure, obesity, and dyslipidemia. Most of these risk factors are modifiable by antidiabetic, antihypertensive, or lipid-lowering treatment and lifestyle changes. Others such as genetic factors or advanced age cannot be modified. Therefore, the rigorous management of the modifiable risk factors is essential for preventing and delaying the decline in renal function. Early diagnosis of diabetic nephropathy is another essential component in the management of diabetes and its complications such as nephropathy. New markers may allow earlier diagnosis of this common and serious complication, but further studies are needed to clarify their additive predictive value, and to define their cost-benefit ratio. This article reviews the most important risk factors in the development and progression of diabetic nephropathy and summarizes recent developments in the diagnosis of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
Kovesdy, C. P., Furth, S. L., Zoccali, C., & on behalf of the World Kidney Day Steering Committee (2017) · American Journal of Nephrology · doi:10.1159/000458467 · Cited by 2,217
MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS
Viberti, G. C., Jarrett, R. J., Mahmud, U., Hill, R. D., Argyropoulos, A., & Keen, H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92450-3 · Cited by 1,663
Predicting Diabetic Nephropathy in Insulin-Dependent Patients
Mogensen, C. E., & Christensen, C. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407123110204 · Cited by 1,569
Standards of Medical Care in Diabetes 2014
(2014) · Majmaah Journal of Health Sciences · doi:10.12816/0004790 · Cited by 1,465
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Stevens, L. A., Coresh, J., Schmid, C. H., Feldman, H. I., Froissart, M., Kusek, J., Rossert, J., Van Lente, F., Bruce, R. D., Zhang, Y. (., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.018 · Cited by 1,037
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
Familial Clustering of Diabetic Kidney Disease
Seaquist, E. R., Goetz, F. C., Rich, S., & Barbosa, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201801 · Cited by 994
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
Barnett, A. H., Bain, S. C., Bouter, P., Karlberg, B., Madsbad, S., Jervell, J., & Mustonen, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042274 · Cited by 910
Regression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Tonelli, M., Muntner, P., Lloyd, A., Manns, B. J., Klarenbach, S., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60572-8 · Cited by 718
Obesity and Risk for Chronic Renal Failure
Ejerblad, E., Fored, C. M., Lindblad, P., Fryzek, J., McLaughlin, J. K., & Nyrén, O. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005060638 · Cited by 680
Michels, W. M., Grootendorst, D. C., Verduijn, M., Elliott, E. G., Dekker, F. W., & Krediet, R. T. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06870909 · Cited by 664
Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652
Kramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618 · cited 4×
“In contrast, in T2D, almost 50% of patients with nephropathy do not have retinopathy [31, 45, 46].”
BackgroundInfluentialPathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
Orchard, T. J., Dorman, J. S., Maser, R. E., Becker, D. J., Drash, A. L., Ellis, D., LaPorte, R. E., & Kuller, L. H. (1990) · Diabetes · doi:10.2337/diab.39.9.1116 · Cited by 540
Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
Niewczas, M. A., Gohda, T., Skupien, J., Smiles, A. M., Walker, W. H., Rosetti, F., Cullere, X., Eckfeldt, J. H., Doria, A., Mayadas, T. N., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060627 · Cited by 485
Declining Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus
Bojestig, M., Arnqvist, H. J., Hermansson, G., Karlberg, B. E., & Ludvigsson, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401063300103 · Cited by 453
Parving, H.-H., Hommel, E., Mathiesen, E., Skott, P., Edsberg, B., Bahnsen, M., Lauritzen, M., Hougaard, P., & Lauritzen, E. (1988) · BMJ · doi:10.1136/bmj.296.6616.156 · Cited by 448
Gall, M.-A., Hougaard, P., Borch-Johnsen, K., & Parving, H.-H. (1997) · BMJ · doi:10.1136/bmj.314.7083.783 · Cited by 445
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
Parving, H.-H., Gall, M.-A., Skøtt, P., Jørgensen, H. E., Løkkegaard, H., Jørgensen, F., Nielsen, B., & Larsen, S. (1992) · Kidney International · doi:10.1038/ki.1992.118 · Cited by 440
Hovind, P., Tarnow, L., Rossing, P., Graae, M., Torp, I., Binder, C., & Parving, H.-H. (2004) · BMJ · doi:10.1136/bmj.38070.450891.fe · Cited by 432
Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
MacIsaac, R. J., Tsalamandris, C., Panagiotopoulos, S., Smith, T. J., McNeil, K. J., & Jerums, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.195 · Cited by 411
Pettitt, D. J., Saad, M. F., Bennett, P. H., Nelson, R. G., & Knowler, W. C. (1990) · Diabetologia · doi:10.1007/bf00404096 · Cited by 393
Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Gohda, T., Niewczas, M. A., Ficociello, L. H., Walker, W. H., Skupien, J., Rosetti, F., Cullere, X., Johnson, A. C., Crabtree, G., Smiles, A. M., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060628 · Cited by 356
Athyros, V. G., Mikhailidis, D. P., Papageorgiou, A. A., Symeonidis, A. N., Pehlivanidis, A. N., Bouloukos, V. I., & Elisaf, M. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.012989 · Cited by 353
Self-citationde Boer, I. H. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.16 · Cited by 351
Magee, G. M., Bilous, R. W., Cardwell, C. R., Hunter, S. J., Kee, F., & Fogarty, D. G. (2009) · Diabetologia · doi:10.1007/s00125-009-1268-0 · Cited by 345
Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies
Morales, E., Valero, M., León, M., Hernández, E., & Praga, M. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50039 · Cited by 327
Perkins, B. A., Nelson, R. G., Ostrander, B. E. P., Blouch, K. L., Krolewski, A. S., Myers, B. D., & Warram, J. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100854 · Cited by 323
Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., Lachin, J., & for the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1098 · Cited by 306
Shepherd, J., Kastelein, J. J. P., Bittner, V., Deedwania, P., Breazna, A., Dobson, S., Wilson, D. J., Zuckerman, A., & Wenger, N. K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.072 · Cited by 302
Rudberg, S., Persson, B., & Dahlquist, G. (1992) · Kidney International · doi:10.1038/ki.1992.126 · Cited by 296
Mussap, M., Vestra, M. D., Fioretto, P., Saller, A., Varagnolo, M., Nosadini, R., & Plebani, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00253.x · Cited by 292
Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes
Pezzolesi, M. G., Poznik, G. D., Mychaleckyj, J. C., Paterson, A. D., Barati, M. T., Klein, J. B., Ng, D. P. K., Placha, G., Canani, L. H., Bochenski, J., et al. (2009) · Diabetes · doi:10.2337/db08-1514 · Cited by 291
Perkins, B. A., Ficociello, L. H., Roshan, B., Warram, J. H., & Krolewski, A. S. (2010) · Kidney International · doi:10.1038/ki.2009.399 · Cited by 289
Urinary Proteomics in Diabetes and CKD
Rossing, K., Mischak, H., Dakna, M., Zürbig, P., Novak, J., Julian, B. A., Good, D. M., Coon, J. J., Tarnow, L., & Rossing, P. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091025 · Cited by 283
Shepherd, J., Kastelein, J. J. P., Bittner, V., Deedwania, P., Breazna, A., Dobson, S., Wilson, D. J., Zuckerman, A., & Wenger, N. K. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04371206 · Cited by 275
Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
Zürbig, P., Jerums, G., Hovind, P., MacIsaac, R. J., Mischak, H., Nielsen, S. E., Panagiotopoulos, S., Persson, F., & Rossing, P. (2012) · Diabetes · doi:10.2337/db12-0348 · Cited by 266
Vaidya, V. S., Niewczas, M. A., Ficociello, L. H., Johnson, A. C., Collings, F. B., Warram, J. H., Krolewski, A. S., & Bonventre, J. V. (2011) · Kidney International · doi:10.1038/ki.2010.404 · Cited by 234
Ridker, P. M., MacFadyen, J., Cressman, M., & Glynn, R. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.020 · Cited by 220
Factors Associated With Frequent Remission of Microalbuminuria in Patients With Type 2 Diabetes
Araki, S.-I., Haneda, M., Sugimoto, T., Isono, M., Isshiki, K., Kashiwagi, A., & Koya, D. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2983 · Cited by 216
Brancati, F. L. (1992) · JAMA · doi:10.1001/jama.268.21.3079 · Cited by 208
Tapp, R. J., Shaw, J. E., Zimmet, P. Z., Balkau, B., Chadban, S. J., Tonkin, A. M., Welborn, T. A., & Atkins, R. C. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)01079-0 · Cited by 186
Biomarkers in diabetic nephropathy: Present and future
Currie, G. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.763 · Cited by 182
Murata, K., Baumann, N. A., Saenger, A. K., Larson, T. S., Rule, A. D., & Lieske, J. C. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02300311 · Cited by 178
de Boer, I. H., Sibley, S. D., Kestenbaum, B., Sampson, J. N., Young, B., Cleary, P. A., Steffes, M. W., Weiss, N. S., & Brunzell, J. D. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040394 · Cited by 165
Hinokio, Y., Suzuki, S., Hirai, M., Suzuki, C., Suzuki, M., & Toyota, T. (2002) · Diabetologia · doi:10.1007/s00125-002-0831-8 · Cited by 160
Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics
Wolkow, P. P., Niewczas, M. A., Perkins, B., Ficociello, L. H., Lipinski, B., Warram, J. H., & Krolewski, A. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050556 · Cited by 155 · cited 1×
“Patients with T1D or T2D and with higher levels of proinflammatory cytokines and chemokines (interleukin 6, interleukin 18, and monocyte chemoattractant protein-1), high-sensitivity Creactive protein (hsCRP, a marker of subclinical inflammation), or adhesion molecules (soluble vascular cellular adhesion molecule-1 and…”
BackgroundCauses of albuminuria in patients with type 2 diabetes without diabetic retinopathy
Christensen, P. K., Larsen, S., Horn, T. D., Olsen, S., & Parving, H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00333.x · Cited by 139
Chandrajay, D. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.201016 · Cited by 137
Saiki, A., Nagayama, D., Ohira, M., Endoh, K., Ohtsuka, M., Koide, N., Oyama, T., Miyashita, Y., & Shirai, K. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803009 · Cited by 123
Kern, E. F. O., Erhard, P., Sun, W., GENUTH, S. M., & Weiss, M. F. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.009 · Cited by 105
Boright, A. P., Paterson, A. D., Mirea, L., Bull, S. B., Mowjoodi, A., Scherer, S. W., & Zinman, B. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1238 · Cited by 102
Nielsen, S. E., Reinhard, H., Zdunek, D., Heß, G., Gutiérrez, O. M., Wolf, M. S., Parving, H., Jacobsen, P. K., & Rossing, P. R. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.007 · Cited by 101
Renal Outcomes in Patients with Type 1 Diabetes and Macroalbuminuria
de Boer, I. H., Afkarian, M., Rue, T. C., Cleary, P. A., Lachin, J. M., Molitch, M. E., Steffes, M. W., Sun, W., & Zinman, B. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013091004 · Cited by 101
Jeffers, B. W., Estacio, R. O., Raynolds, M. V., & Schrier, R. W. (1997) · Kidney International · doi:10.1038/ki.1997.355 · Cited by 100
Narita, T., Hosoba, M., Kakei, M., & Ito, S. (2006) · Diabetes Care · doi:10.2337/diacare.29.1.142 · Cited by 100
Nielsen, S. E., Andersen, S., Zdunek, D., Heß, G., Parving, H., & Rossing, P. R. (2011) · Kidney International · doi:10.1038/ki.2010.554 · Cited by 99
Persson, F., Rossing, P. R., Hovind, P. H., Stehouwer, C. D. A., Schalkwijk, C. G., Tarnow, L., & Parving, H. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802187226 · Cited by 88
Araki, S., Haneda, M., Koya, D., Sugimoto, T., Isshiki, K., Chin‒Kanasaki, M., Uzu, T., & Kashiwagi, A. (2007) · Diabetologia · doi:10.1007/s00125-006-0586-8 · Cited by 81
Microalbuminuria and risk factors in type 1 and type 2 diabetic patients
Cederholm, J., Eliasson, B., Nilsson, P.-E., Weiss, L. G., & Guðbjörnsdóttir, S. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.07.021 · Cited by 80
Shah, V. O., Scavini, M., Nikolic, J., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5028 · Cited by 79
Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus.
Gambaro, G., Bax, G., Fusaro, M., Normanno, M., Manani, S. M., Zanella, M. T., D’Angelo, A., Fedele, D., & Favaro, S. (2001) · PubMed · Cited by 78
Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy
Hadjadj, S., Tarnow, L., Forsblom, C. M., Kazeem, G., Marre, M., Groop, P., Parving, H. H., Cambien, F., Trégouët, D., Gut, I. G., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101102 · Cited by 75
Pavkov, M. E., Knowler, W. C., Bennett, P. H., Looker, H. C., Krakoff, J. A., & Nelson, R. G. (2006) · Kidney International · doi:10.1038/sj.ki.5001882 · Cited by 74
Chou, K.-M., Lee, C., Chen, C.-H., & Sun, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054863 · Cited by 67
Schlatzer, D., Maahs, D. M., Chance, M. R., Dazard, J.-E., Li, X., Hazlett, F. E., Rewers, M., & Snell‐Bergeon, J. K. (2012) · Diabetes Care · doi:10.2337/dc11-1491 · Cited by 66
Iliadis, F. S., Didangelos, T., Ntemka, A., Makedou, A., Moralidis, E., Gotzamani-Psarakou, A., Kouloukourgiotou, T., & Grekas, D. M. (2011) · Diabetologia · doi:10.1007/s00125-011-2307-1 · Cited by 65
Genomewide Linkage Scan for Diabetic Renal Failure and Albuminuria: The FIND Study
Igo, R. P., Iyengar, S. K., Nicholas, S. B., Goddard, K. A. B., Langefeld, C. D., Hanson, R. L., Duggirala, R., Divers, J., Abboud, H. E., Adler, S. G., et al. (2011) · American Journal of Nephrology · doi:10.1159/000326763 · Cited by 62
Conway, B. R., Manoharan, D., Manoharan, D., Jenks, S. J., Dear, J. W., McLachlan, S., Strachan, M. W. J., & Price, J. F. (2012) · Kidney International · doi:10.1038/ki.2012.218 · Cited by 62
Ronald, C. W., Tam, C. H. T., Wang, Y., Luk, A. O., Hu, C., Yang, X., Lam, V., Chan, A. W. H., Ho, J. S. K., Chow, C.-C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1191 · Cited by 61
Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
Kazumi, T., Hozumi, T., Ishida, Y., et al. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1176 · Cited by 54
How Reliable Is Estimation of Glomerular Filtration Rate at Diagnosis of Type 2 Diabetes?
Chudleigh, R. A., Dunseath, G., Evans, W., Harvey, J. N., Evans, P., Ollerton, R., & Owens, D. R. (2007) · Diabetes Care · doi:10.2337/dc06-1688 · Cited by 49
Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy
Satko, S. G., Langefeld, C. D., Daeihagh, P., Bowden, D. W., Rich, S. S., & Freedman, B. I. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34888 · Cited by 42
Shah, V. O. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2886 · Cited by 38
Pettersson-Fernholm, K., Fröjdö, S., Fagerudd, J. A., Thomas, M. C., Forsblom, C. M., Wessman, M., & Groop, P. (2006) · Kidney International · doi:10.1038/sj.ki.5000348 · Cited by 31
Regression of Microalbuminuria in Type 1 Diabetes
Catena, C., Novello, M., & Sechi, L. A. (2003) · New England Journal of Medicine · doi:10.1056/nejm200308283490915 · Cited by 30
Thameem, F., Igo, R. P., Freedman, B. I., Langefeld, C. D., Hanson, R. L., Schelling, J. R., Elston, R. C., Duggirala, R., Nicholas, S. B., Goddard, K. A. B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081888 · Cited by 28
Garrick, R. (2010) · Yearbook of Medicine · doi:10.1016/s0084-3873(10)79707-8 · Cited by 20
Hyperfiltration in patients with type I diabetes mellitus: a prevalence study.
Cotroneo, P., Manto, A., Todaro, L., Manto, A., Pitocco, D., Saponara, C., Vellante, C., Maussier, M. L., D'Errico, G., Magnani, P., et al. (1998) · PubMed · Cited by 15
Cited by
Shi, G.-J., Li, Y., Cao, Q.-H., Wu, H.-X., Tang, X.-Y., Gao, X.-H., Yu, J.-Q., Chen, Z., & Yang, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.130 · Cited by 299
A metabolic handbook for the COVID-19 pandemic
Ayres, J. S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0237-2 · Cited by 292
Impact of stopping smoking on metabolic parameters in diabetes mellitus: A scoping review
Walicka, M., Russo, C., Baxter, M., John, I., Caci, G., & Polosa, R. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i6.422 · Cited by 30
Predicting diabetic nephropathy in type 2 diabetic patients using machine learning algorithms
Hosseini Sarkhosh, S. M., Esteghamati, A., Hemmatabadi, M., & Daraei, M. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01076-2 · Cited by 24
Kobe, E. A., Diamantidis, C. J., Bosworth, H. B., Davenport, C. A., Oakes, M., Alexopoulos, A.-S., Pendergast, J., Patel, U. D., & Crowley, M. J. (2020) · Medical Care · doi:10.1097/mlr.0000000000001387 · Cited by 15
Metadata
- Authors
- Tziomalos, K., & Athyros, V. G.
- Venue
- The Review of Diabetic Studies
- Publisher
- Raiya Academic International LLC
- Published
- 2015
- Volume
- 12
- Issue
- 1-2
- Pages
- 110-118
- ISSN
- 1613-6071 (ISSN-L)
- 1614-0575
- OpenAlex
- W2210163103
- Cited by
- 268
- References
- 98
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.